10/30/2024 8:25 AM | Dogwood Therapeutics, Inc. (Filer) Dogwood Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/17/2024 3:29 PM | Dogwood Therapeutics, Inc. (Issuer) Dogwood Therapeutics (Issuer) Toh Kean Meng Melvin (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
10/17/2024 3:30 PM | Dogwood Therapeutics, Inc. (Issuer) Dogwood Therapeutics (Issuer) Yu Ying Choi Alan Abel (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
10/17/2024 3:29 PM | CK Life Sciences Intl Inc (0001297567) (Reporting) Dogwood Therapeutics, Inc. (Issuer) Dogwood Therapeutics (Issuer) Sealbond Ltd (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
10/15/2024 3:19 PM | Sealbond Ltd (Filed by) Virios Therapeutics, Inc. (Subject) Dogwood Therapeutics (Subject)
| Form SC 13D | |
10/07/2024 7:06 AM | Virios Therapeutics, Inc. (Filer) Dogwood Therapeutics (Filer)
| Form DEFA14A | |
10/07/2024 7:02 AM | Virios Therapeutics, Inc. (Filer) Dogwood Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
08/09/2024 9:15 AM | Virios Therapeutics, Inc. (Filer) Dogwood Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024 8:30 AM | Virios Therapeutics, Inc. (Filer) Dogwood Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/20/2024 8:15 AM | Virios Therapeutics, Inc. (Filer) Dogwood Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/12/2024 8:15 AM | Virios Therapeutics, Inc. (Filer) Dogwood Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/20/2024 8:28 AM | Virios Therapeutics, Inc. (Filer) Dogwood Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/10/2024 9:30 AM | Virios Therapeutics, Inc. (Filer) Dogwood Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024 7:01 AM | Virios Therapeutics, Inc. (Filer) Dogwood Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/07/2024 4:25 PM | Virios Therapeutics, Inc. (Filer) Dogwood Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/29/2024 4:26 PM | Virios Therapeutics, Inc. (Filer) Dogwood Therapeutics (Filer)
| Form ARS | |
04/25/2024 3:33 PM | Virios Therapeutics, Inc. (Filer) Dogwood Therapeutics (Filer)
| Form DEF 14A | |
03/01/2024 8:10 AM | Virios Therapeutics, Inc. (Filer) Dogwood Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/29/2024 8:25 AM | Virios Therapeutics, Inc. (Filer) Dogwood Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/28/2024 11:43 AM | Gendreau Roger Michael (Reporting) Virios Therapeutics, Inc. (Issuer) Dogwood Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 11:47 AM | Grosswald Ralph (Reporting) Virios Therapeutics, Inc. (Issuer) Dogwood Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 11:51 AM | Virios Therapeutics, Inc. (Issuer) Dogwood Therapeutics (Issuer) Walsh Angela (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 11:54 AM | De La Rosa Abel (Reporting) Virios Therapeutics, Inc. (Issuer) Dogwood Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 11:40 AM | Duncan Gregory Scott (Reporting) Virios Therapeutics, Inc. (Issuer) Dogwood Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 3:21 PM | Virios Therapeutics, Inc. (Filer) Dogwood Therapeutics (Filer)
| Form DEFA14A | |
02/13/2024 5:01 PM | Corday Brian David (Filed by) Virios Therapeutics, Inc. (Subject) Dogwood Therapeutics (Subject)
| Form SC 13G/A | |
02/02/2024 3:31 PM | Virios Therapeutics, Inc. (Filer) Dogwood Therapeutics (Filer)
| Form DEF 14A | |
02/02/2024 3:31 PM | Virios Therapeutics, Inc. (Filer) Dogwood Therapeutics (Filer)
| Form DEF 14A | |
01/22/2024 8:33 AM | Virios Therapeutics, Inc. (Filer) Dogwood Therapeutics (Filer)
| Form PRE 14A | |
01/03/2024 6:05 AM | Virios Therapeutics, Inc. (Filer) Dogwood Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2023 8:10 AM | Virios Therapeutics, Inc. (Filer) Dogwood Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/13/2023 6:20 AM | Virios Therapeutics, Inc. (Filer) Dogwood Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/07/2023 6:29 AM | Virios Therapeutics, Inc. (Filer) Dogwood Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/02/2023 6:05 AM | Virios Therapeutics, Inc. (Filer) Dogwood Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |